Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Vaccines

  Free Subscription


15.05.2017

2 Clin Infect Dis
1 Indian Pediatr
1 J Gen Virol
1 J Infect
2 J Infect Dis
1 J Pediatr
13 J Virol
2 JAMA
2 Lancet Infect Dis
1 MMWR Morb Mortal Wkly Rep
1 N Engl J Med
1 Pediatr Infect Dis J
1 PLoS Med
6 PLoS One
21 Vaccine
1 Virus Res


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Clin Infect Dis

  1. BARDENHEIER BH, McNeil MM, Wodi AP, McNicholl J, et al
    Risk of non-targeted infectious disease hospitalizations among U.S. children following inactivated and live vaccines, 2005-2014.
    Clin Infect Dis. 2017 May 6. doi: 10.1093.
    PubMed     Text format     Abstract available

  2. YIN JK, Heywood AE, Georgousakis M, King C, et al
    Systematic review and meta-analysis of indirect protection afforded by vaccinating children against seasonal influenza: implications for policy.
    Clin Infect Dis. 2017 May 5. doi: 10.1093.
    PubMed     Text format     Abstract available


    Indian Pediatr

  3. RAOOT A, Dewan DK, Dubey AP, Seth S, et al
    Introduction of New Vaccines in State Immunization Schedule - Delhi's Experience.
    Indian Pediatr. 2017;54:271-274.
    PubMed     Text format     Abstract available


    J Gen Virol

  4. ZHANG Y, Zhou M, Wang Z, Yang J, et al
    Recombinant rabies virus expressing IL-21 enhances immunogenicity through activation of T follicular helper cells and germinal center B cells.
    J Gen Virol. 2016 Oct 25. doi: 10.1099/jgv.0.000646.
    PubMed     Text format     Abstract available


    J Infect

  5. HARDER T, Koch J, Wichmann O, Hellenbrand W, et al
    Predicted vs observed effectiveness of outer membrane vesicle (OMV) vaccines against meningococcal serogroup B disease: systematic review.
    J Infect. 2017 May 6. pii: S0163-4453(17)30135.
    PubMed     Text format     Abstract available


    J Infect Dis

  6. JEGASKANDA S, Co MD, Cruz J, Subbarao K, et al
    Human seasonal influenza A viruses induce H7N9-cross-reactive antibody-dependent cellular cytotoxicity (ADCC) antibodies that are directed towards the nucleoprotein.
    J Infect Dis. 2016 Dec 23. pii: jiw629. doi: 10.1093.
    PubMed     Text format     Abstract available

  7. WANG X, Fan X, Bi S, Li N, et al
    Toll-like Receptor 2-and 4-Mediated Reciprocal Th17 and Antibody Responses to Group A Streptococcus Infection.
    J Infect Dis. 2016 Dec 23. pii: jiw598. doi: 10.1093.
    PubMed     Text format     Abstract available


    J Pediatr

  8. CASILLAS SM, Bednarczyk RA
    Missed Opportunities for Hepatitis A Vaccination, National Immunization Survey-Child, 2013.
    J Pediatr. 2017 May 5. pii: S0022-3476(17)30484.
    PubMed     Text format     Abstract available


    J Virol

  9. AYALA VI, Trivett MT, Barsov EV, Jain S, et al
    Adoptive Transfer of Engineered Rhesus SIV-Specific CD8+ T Cells Reduces the Number of Transmitted/Founder Viruses Established in Rhesus Macaques.
    J Virol. 2016 Aug 24. pii: JVI.01522.
    PubMed     Text format     Abstract available

  10. LIU L, Zeng X, Chen P, Deng G, et al
    Characterization of Clade 7.2 H5 Avian Influenza Viruses That Continue to Circulate in Chickens in China.
    J Virol. 2016 Aug 24. pii: JVI.00855.
    PubMed     Text format     Abstract available

  11. VERKERKE HP, Williams JA, Guttman M, Simonich CA, et al
    Epitope-independent purification of native-like envelope trimers from diverse HIV-1 isolates.
    J Virol. 2016 Aug 10. pii: JVI.01351.
    PubMed     Text format     Abstract available

  12. TALKER SC, Stadler M, Koinig HC, Mair KH, et al
    Influenza A virus infection in pigs attracts multifunctional and cross-reactive T cells to the lung.
    J Virol. 2016 Aug 10. pii: JVI.01211.
    PubMed     Text format     Abstract available

  13. LIANG Y, Guttman M, Williams JA, Verkerke H, et al
    Changes in structure and antigenicity of HIV-1 Env trimers resulting from removal of a conserved CD4 binding site-proximal glycan.
    J Virol. 2016 Aug 3. pii: JVI.01116.
    PubMed     Text format     Abstract available

  14. TOWNSLEY S, Mohamed Z, Guo W, McKenna J, et al
    Induction of heterologous Tier 2 HIV-1 neutralizing and cross-reactive V1/V2-specific antibodies in rabbits by prime-boost immunization.
    J Virol. 2016 Jul 20. pii: JVI.00853.
    PubMed     Text format     Abstract available

  15. LIANG B, Ngwuta JO, Herbert R, Swerczek J, et al
    Packaging and prefusion stabilization separately and additively increase the quantity and quality of RSV-neutralizing antibodies induced by respiratory syncytial virus (RSV) fusion protein expressed by a parainfluenza vector.
    J Virol. 2016 Aug 31. pii: JVI.01196.
    PubMed     Text format     Abstract available

  16. ALTENBURG AF, van de Sandt CE, van Trierum SE, De Gruyter HL, et al
    Increased Protein Degradation Improves Influenza Virus Nucleoprotein-specific CD8+ T cell Activation in vitro but not in C57BL/6 mice.
    J Virol. 2016 Aug 31. pii: JVI.01633.
    PubMed     Text format     Abstract available

  17. SCHNEIDER-OHRUM K, Cayatte C, Liu Y, Wang Z, et al
    Production of cytomegalovirus dense bodies by scalable bioprocess methods maintains immunogenicity and improves neutralizing antibody titers.
    J Virol. 2016 Aug 31. pii: JVI.00463.
    PubMed     Text format     Abstract available

  18. CRUZ AGB, Han A, Roy EJ, Guzman AB, et al
    Deletion of the K1L gene results in a vaccinia virus that is less pathogenic due to muted innate immune responses, yet still elicits protective immunity.
    J Virol. 2017 May 10. pii: JVI.00542-17. doi: 10.1128/JVI.00542.
    PubMed     Text format     Abstract available

  19. HYUN SI, Weisberg A, Moss B
    Deletion of the Vaccinia Virus I2 Protein Interrupts Virion Morphogenesis Leading to Retention of the Scaffold Protein and Mislocalization of Membrane-Associated Entry Proteins.
    J Virol. 2017 May 10. pii: JVI.00558-17. doi: 10.1128/JVI.00558.
    PubMed     Text format     Abstract available

  20. BOONNAK K, Matsuoka Y, Wang W, Suguitan AL Jr, et al
    Development of clade-specific and broadly reactive live attenuated influenza virus vaccines against rapidly evolving H5 subtype viruses.
    J Virol. 2017 May 10. pii: JVI.00547-17. doi: 10.1128/JVI.00547.
    PubMed     Text format     Abstract available

  21. WIBMER CK, Gorman J, Anthony CS, Mkhize NN, et al
    Structure of an N276-dependent HIV-1 Neutralizing Antibody Targeting a Rare V5 Glycan Hole adjacent to the CD4 Binding Site.
    J Virol. 2016 Aug 31. pii: JVI.01357.
    PubMed     Text format     Abstract available


    JAMA

  22. HALABI SF, Omer SB
    Legal Complexities of Global Vaccine Compensation Systems-Reply.
    JAMA. 2017;317:1912.
    PubMed     Text format    

  23. MASTROIANNI AC, Henry LM
    Legal Complexities of Global Vaccine Compensation Systems.
    JAMA. 2017;317:1911-1912.
    PubMed     Text format    


    Lancet Infect Dis

  24. O'RYAN M, Lopman BA
    Parenteral protein-based rotavirus vaccine.
    Lancet Infect Dis. 2017 May 5. pii: S1473-3099(17)30244.
    PubMed     Text format    

  25. GROOME MJ, Koen A, Fix A, Page N, et al
    Safety and immunogenicity of a parenteral P2-VP8-P[8] subunit rotavirus vaccine in toddlers and infants in South Africa: a randomised, double-blind, placebo-controlled trial.
    Lancet Infect Dis. 2017 May 5. pii: S1473-3099(17)30242.
    PubMed     Text format     Abstract available


    MMWR Morb Mortal Wkly Rep

  26. WONG KK, Burdette E, Mahon BE, Mintz ED, et al
    Recommendations of the Advisory Committee on Immunization Practices for Use of Cholera Vaccine.
    MMWR Morb Mortal Wkly Rep. 2017;66:482-485.
    PubMed     Text format     Abstract available


    N Engl J Med

  27. THOMAS SJ
    Zika Virus Vaccines - A Full Field and Looking for the Closers.
    N Engl J Med. 2017;376:1883-1886.
    PubMed     Text format    


    Pediatr Infect Dis J

  28. BASSAL R, Weil M, Cohen D, Sofer D, et al
    Seroprevalence of Hepatitis A 12-years Following the Implementation of Toddlers' Vaccination: A Population Based Study in Israel.
    Pediatr Infect Dis J. 2017 May 11. doi: 10.1097/INF.0000000000001640.
    PubMed     Text format     Abstract available


    PLoS Med

  29. KIRKWOOD CD, Steele AD
    Rotavirus vaccine will have an impact in Asia.
    PLoS Med. 2017;14:e1002298.
    PubMed     Text format     Abstract available


    PLoS One

  30. MORTENSEN R, Christensen D, Hansen LB, Christensen JP, et al
    Local Th17/IgA immunity correlate with protection against intranasal infection with Streptococcus pyogenes.
    PLoS One. 2017;12:e0175707.
    PubMed     Text format     Abstract available

  31. HEO JY, Seo YB, Choi WS, Lee J, et al
    Cost-effectiveness of pneumococcal vaccination strategies for the elderly in Korea.
    PLoS One. 2017;12:e0177342.
    PubMed     Text format     Abstract available

  32. VON REYN CF, Lahey T, Arbeit RD, Landry B, et al
    Safety and immunogenicity of an inactivated whole cell tuberculosis vaccine booster in adults primed with BCG: A randomized, controlled trial of DAR-901.
    PLoS One. 2017;12:e0175215.
    PubMed     Text format     Abstract available

  33. GILBERT PB, Excler JL, Tomaras GD, Carpp LN, et al
    Antibody to HSV gD peptide induced by vaccination does not protect against HSV-2 infection in HSV-2 seronegative women.
    PLoS One. 2017;12:e0176428.
    PubMed     Text format     Abstract available

  34. VAN AALST S, Ludwig IS, van der Zee R, van Eden W, et al
    Bystander activation of irrelevant CD4+ T cells following antigen-specific vaccination occurs in the presence and absence of adjuvant.
    PLoS One. 2017;12:e0177365.
    PubMed     Text format     Abstract available

  35. HAUSE AM, Henke DM, Avadhanula V, Shaw CA, et al
    Sequence variability of the respiratory syncytial virus (RSV) fusion gene among contemporary and historical genotypes of RSV/A and RSV/B.
    PLoS One. 2017;12:e0175792.
    PubMed     Text format     Abstract available


    Vaccine

  36. IDOKO OT, Mboizi RB, Okoye M, Laudat F, et al
    Immunogenicity and safety of 13-valent pneumococcal conjugate vaccine (PCV13) formulated with 2-phenoxyethanol in multidose vials given with routine vaccination in healthy infants: An open-label randomized controlled trial.
    Vaccine. 2017 May 4. pii: S0264-410X(17)30541.
    PubMed     Text format     Abstract available

  37. IZAC JR, Oliver LD Jr, Earnhart CG, Marconi RT, et al
    Identification of a defined linear epitope in the OspA protein of the Lyme disease spirochetes that elicits bactericidal antibody responses: Implications for vaccine development.
    Vaccine. 2017 May 4. pii: S0264-410X(17)30580.
    PubMed     Text format     Abstract available

  38. PARK SH, Kim SA, Rubinelli PM, Roto SM, et al
    Microbial compositional changes in broiler chicken cecal contents from birds challenged with different Salmonella vaccine candidate strains.
    Vaccine. 2017 May 4. pii: S0264-410X(17)30574.
    PubMed     Text format     Abstract available

  39. WONG CKH, Liao Q, Guo VYW, Xin Y, et al
    Cost-effectiveness analysis of vaccinations and decision makings on vaccination programmes in Hong Kong: A systematic review.
    Vaccine. 2017 May 2. pii: S0264-410X(17)30542.
    PubMed     Text format     Abstract available

  40. SAHIN Z, Akkoc S, Neeleman R, Haines J, et al
    Nile Red fluorescence spectrum decomposition enables rapid screening of large protein aggregates in complex biopharmaceutical formulations like influenza vaccines.
    Vaccine. 2017 May 2. pii: S0264-410X(17)30558.
    PubMed     Text format     Abstract available

  41. HOSHI SL, Kondo M, Okubo I
    Cost-effectiveness of varicella vaccine against herpes zoster and post-herpetic neuralgia for elderly in Japan.
    Vaccine. 2017 May 4. pii: S0264-410X(17)30537.
    PubMed     Text format     Abstract available

  42. BOGGIANO C, Eichelberg K, Ramachandra L, Shea J, et al
    "The Impact of Mycobacterium tuberculosis Immune Evasion on Protective Immunity: Implications for TB Vaccine Design" - Meeting report.
    Vaccine. 2017 May 2. pii: S0264-410X(17)30467.
    PubMed     Text format     Abstract available

  43. SALEEM AF, Mach O, Yousafzai MT, Khan A, et al
    Needle adapters for intradermal administration of fractional dose of inactivated poliovirus vaccine: Evaluation of immunogenicity and programmatic feasibility in Pakistan.
    Vaccine. 2017 May 4. pii: S0264-410X(17)30576.
    PubMed     Text format     Abstract available

  44. DE OLIVEIRA JS, Costa GB, Franco Luiz APM, Leite JA, et al
    Cross-sectional study involving healthcare professionals in a Vaccinia virus endemic area.
    Vaccine. 2017 May 8. pii: S0264-410X(17)30540.
    PubMed     Text format     Abstract available

  45. ARAFAT N, Eladl AH, Mahgoub H, El-Shafei RA, et al
    Effect of infectious bursal disease (IBD) vaccine on Salmonella Enteritidis infected chickens.
    Vaccine. 2017 May 8. pii: S0264-410X(17)30577.
    PubMed     Text format     Abstract available

  46. WON G, Kim B, Lee JH
    A novel approach for construction of an inactivated typhoid vaccine candidate that effectively augments both humoral and cellular immune responses.
    Vaccine. 2017 May 8. pii: S0264-410X(17)30585.
    PubMed     Text format     Abstract available

  47. BROKER M, Berti F, Schneider J, Vojtek I, et al
    Polysaccharide conjugate vaccine protein carriers as a "neglected valency" - Potential and limitations.
    Vaccine. 2017 May 6. pii: S0264-410X(17)30579.
    PubMed     Text format     Abstract available

  48. DENG Y, Chuai X, Chen P, Chen H, et al
    Recombinant vaccinia vector-based vaccine (Tiantan) boosting a novel HBV subunit vaccine induced more robust and lasting immunity in rhesus macaques.
    Vaccine. 2017 May 6. pii: S0264-410X(17)30551.
    PubMed     Text format     Abstract available

  49. CHADA KE, Forshee R, Golding H, Anderson S, et al
    A systematic review and meta-analysis of cross-reactivity of antibodies induced by oil-in-water emulsion adjuvanted influenza H5N1 virus monovalent vaccines.
    Vaccine. 2017 May 5. pii: S0264-410X(17)30507.
    PubMed     Text format     Abstract available

  50. FONSECA JA, McCaffery JN, Kashentseva E, Singh B, et al
    A prime-boost immunization regimen based on a simian adenovirus 36 vectored multi-stage malaria vaccine induces protective immunity in mice.
    Vaccine. 2017 May 5. pii: S0264-410X(17)30554.
    PubMed     Text format     Abstract available

  51. MANGEN MJ, Stibbe H, Urbanus A, Siedenburg EC, et al
    Targeted outreach hepatitis B vaccination program in high-risk adults: The fundamental challenge of the last mile.
    Vaccine. 2017 May 5. pii: S0264-410X(17)30560.
    PubMed     Text format     Abstract available

  52. IRO MA, Snape MD, Voysey M, Jawad S, et al
    Corrigendum to "Persistence of bactericidal antibodies following booster vaccination with 4CMenB at 12, 18 or 24months and immunogenicity of a fifth dose administered at 4years of age-a phase 3 extension to a randomised controlled trial" [Vaccine 35 (
    Vaccine. 2017 May 5. pii: S0264-410X(17)30582.
    PubMed     Text format    

  53. PAN H, Li Z, Wang J, Song S, et al
    Bacterially expressed human papillomavirus type 6 and 11 bivalent vaccine: Characterization, antigenicity and immunogenicity.
    Vaccine. 2017 May 5. pii: S0264-410X(17)30556.
    PubMed     Text format     Abstract available

  54. XING J, Xu H, Wang Y, Tang X, et al
    Identification of immunogenic proteins and evaluation of four recombinant proteins as potential vaccine antigens from Vibrio anguillarum in flounder (Paralichthys olivaceus).
    Vaccine. 2017 May 5. pii: S0264-410X(17)30572.
    PubMed     Text format     Abstract available

  55. LI X, Huang J, Kawamura A, Funakoshi R, et al
    Co-localization of a CD1d-binding glycolipid with an adenovirus-based malaria vaccine for a potent adjuvant effect.
    Vaccine. 2017 May 5. pii: S0264-410X(17)30578.
    PubMed     Text format     Abstract available

  56. ZERBO O, Modaressi S, Chan B, Goddard K, et al
    No association between influenza vaccination during pregnancy and adverse birth outcomes.
    Vaccine. 2017 May 5. pii: S0264-410X(17)30575.
    PubMed     Text format     Abstract available


    Virus Res

  57. LI Y, Yan S, Li X, Yang Q, et al
    From mouse to pig: is PRV vaccine safe across two species?
    Virus Res. 2017 May 5. pii: S0168-1702(17)30197.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Vaccines is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: